PubMed HealthSearch

Biomedical subjects

D M Han

Publications and source records attributed to D M Han.

3 recordsLinked to original sources

[Functional endoscopic sinus surgery].

Eighty-two cases of functional endoscopic sinus surgery were analyzed. It include 62 males and 20 females; the oldest was 72 years of age and the youngest eight years of age. A hard endoscope with a diameter of 4mm and the CCD micro-videorecorder produced by Circon and Olympus Company were used. Operations were done under general anesthesia in all cases. Twenty-three cases (28.1%) recovered in one stage and recovery was delayed in 28 cases (34.2%); late inflammation occurred in 23 cases (28.1%); 8 cases failed (9.8%). The cure rate was 62.2%. Two cases (2.4%) had operative complications namely injury to the lamina papyracea and anterior ethmoidal artery, all recovered uneventfully.

Adolescent

Inhibition of topoisomerase I by NAD and enhancement of cytotoxicity of MMS by inhibitors of poly(ADP-ribose) polymerase in Saccharomyces cerevisiae.

The activity of DNA topoisomerase I present in the nuclear extract of yeast, Saccharomyces cerevisiae, was inhibited by additions of NAD, the substrate of poly (ADP-ribose) polymerase. This NAD-inhibited topoisomerase activity was restored to the normal level in a dose-dependent manner by adding 3-aminobenzamide (3-AB), an inhibitor of the polymerase. The 3-AB sensitive polymerase enzyme activity, as determined by the rate of incorporation of the radiolabelled NAD in permeabilized cells, increased by treatment of cells with methyl methanesulfonate (MMS) in a dose-dependent manner. While the additions of MMS increased the polymerase activity, it has caused a decrease in cell survival. However, this cell killing activity of MMS was markedly potentiated by adding benzamide, another inhibitor of polymerase. Thus, these results suggest that the mode of modification of nuclear proteins by altering the poly(ADP-ribosylation) in S. cerevisiae resembles with those observed in mammalian cells.

Benzamides

[Biological characteristics and prognosis of supraglottic carcinoma--a multivariate correlation analysis of prognosis].

The biological characteristics of supraglottic carcinoma was studied with special reference to the correlations of various biological factors with the prognosis of the lesion. The study included 100 cases of supraglottic carcinoma treated by total laryngectomy in the First Hospital of China Medical University in the period from 1975 to 1978, and 7 factors including histopathological findings observed in serial sections of the whole larynx, clinical findings, clinical course, etc. These factors were statistically analyzed by multiple correlation analysis using the theory of quantification I to determine the relations of these factors to the prognosis, as well as their participations in post operative course. 1. Twenty-seven cases died within 5 years after surgery, and 4 cases could not be followed up. 3 and 5-year survival rates were 79.5% and 72.2%, respectively, as calculated in accordance with the UICC General Rule. 2. Histopathologically 5-year survival rate was 10.0% in cases with poorly differentiated carcinoma, 78.0% in cases with moderately differentiated type, and 83.5% in cases with well-differentiated type. It was remarkably lower in poorly differentiated carcinoma than that in moderately or well-differentiated carcinoma. 3. In cases having dense lymphocyte infiltration associated with lymph follicles in peripheral region of tumor, 5-year survival rate was higher (90.4%) than in the other cases. 4. It was found that, as tumor size increased, 5-year survival rate decreased and the risk of lymph node involvement increased in the neck region. 5. 5-year survival rate was lower (48.5%) in cases with lesion infiltrating the surrounding tissues than in cases with other growth patterns. 6. Multiple correlation coefficient between prognosis and the 7 factors analyzed was 0.766. The important factors were the degree of differentiation (0.735), the degree of lymphocyte infiltration (0.260), the size of primary tumor (0.215), the growth pattern of tumor (0.141) and neck metastasis (0.028).

Carcinoma, Squamous Cell